Abstract
Phase 1 Study of Elotuzumab and Peripheral Blood Mononuclear Cell Reconstitution in Combination with Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have